These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21868576)

  • 1. Is heparin a placental anticoagulant in high-risk pregnancies?
    Kingdom JC; Drewlo S
    Blood; 2011 Nov; 118(18):4780-8. PubMed ID: 21868576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: Is it time to put the needles away?
    Skeith L; Rodger M
    Thromb Res; 2017 Mar; 151 Suppl 1():S38-S42. PubMed ID: 28262232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfractionated heparin and placental pathology in high-risk pregnancies: secondary analysis of a pilot randomized controlled trial.
    D'Souza R; Keating S; Walker M; Drewlo S; Kingdom J
    Placenta; 2014 Oct; 35(10):816-23. PubMed ID: 25128485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure.
    Bose P; Black S; Kadyrov M; Weissenborn U; Neulen J; Regan L; Huppertz B
    Am J Obstet Gynecol; 2005 Jan; 192(1):23-30. PubMed ID: 15671997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model.
    An J; Waitara MS; Bordas M; Arumugam V; Hoffmann RG; Petrich BG; Sinha U; North PE; Sood R
    Blood; 2013 Mar; 121(11):2127-34. PubMed ID: 23325830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antithrombin binding regions of heparin mediate fetal growth and reduced placental damage in the RUPP model of preeclampsia†.
    Wat JM; Baczyk D; Kingdom JC
    Biol Reprod; 2020 Apr; 102(5):1102-1110. PubMed ID: 31950133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
    Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
    Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
    Dodd JM; McLeod A; Windrim RC; Kingdom J
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006780. PubMed ID: 23884904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin as a therapeutic model in the treatment of placenta insufficiency].
    Anger H
    Fortschr Med; 1974 Sep; 92(26):1045-8. PubMed ID: 4471827
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
    Dodd JM; McLeod A; Windrim RC; Kingdom J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006780. PubMed ID: 20556769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombophilias and vascular placental pathology. A survey of the literature].
    Verspyck E; Marpeau L
    Rev Med Interne; 2005 Feb; 26(2):103-8. PubMed ID: 15710256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant prophylaxis for placenta mediated pregnancy complications.
    Rodger MA
    Thromb Res; 2011 Feb; 127 Suppl 3():S76-80. PubMed ID: 21262448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Molecular-Weight Heparin for the Prevention of Placenta-mediated Pregnancy Complications.
    Haddad B; Lecarpentier E; Touboul C; Sibai BM
    Clin Obstet Gynecol; 2017 Mar; 60(1):153-160. PubMed ID: 28005590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-occurrence of multifocal chorioangiomatosis and mesenchymal dysplasia in preeclampsia.
    Rosefort A; Cordier AG; Kaddioui S; Beaumont B; Baergen R; Benachi A; Martinovic J
    Pediatr Dev Pathol; 2013; 16(3):206-9. PubMed ID: 23286309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific basis of severe placental dysfunction leading to extreme preterm delivery.
    Walker MG; Fitzgerald B; Keating S; Ray JG; Windrim R; Kingdom JC
    Placenta; 2012 Jul; 33(7):568-71. PubMed ID: 22513321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound diagnosis of severe thrombotic placental damage in the second trimester: an observational study.
    Alkazaleh F; Viero S; Simchen M; Walker M; Smith G; Laskin C; Windrim R; Kingdom J
    Ultrasound Obstet Gynecol; 2004 May; 23(5):472-6. PubMed ID: 15133798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulants to prevent placenta-mediated pregnancy complications: a review of current evidence.
    Dao V; Rodger M
    Curr Opin Hematol; 2009 Sep; 16(5):386-90. PubMed ID: 19550316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMWH to prevent placenta-mediated pregnancy complications: an update.
    Duffett L; Rodger M
    Br J Haematol; 2015 Mar; 168(5):619-38. PubMed ID: 25399526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant therapy of patients with repeated placental infarction.
    Buyse FG; Wormgoor BH; Bernard JT; Koudstaal J
    Obstet Gynecol; 1974 Jun; 43(6):844-8. PubMed ID: 4829279
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.